Analyst firms · Leerink Partners · FOLD

Leerink Partners FOLD price target and rating history

Amicus Therapeutics Inc. (FOLD) · Health Care

Leerink Partners rates Amicus Therapeutics Inc. (FOLD) Market Perform with a $14.50 price target, as of its latest action on Dec 29, 2025. It has published 4 rating actions on FOLD since September 2021, including 1 upgrade and 1 downgrade. Across 4 firms with a FOLD price target in the last 12 months, the median target is $14.50. Leerink Partners's target matches it.

Current rating
Market Perform
Price target
$14.50
Median target, all firms
$14.50
Actions on FOLD
4

Leerink Partners price target on FOLD

$16$14$1220222023202420252026
Leerink Partners price target on FOLD, each point a stated target, September 2021 to December 2025.

Every Leerink Partners rating on FOLD

How other firms rate FOLD

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
JefferiesHold$14.50Jan 22, 2026
Leerink PartnersMarket Perform$14.50Dec 29, 2025
TD CowenHold$14.50Dec 22, 2025
CitigroupBuy$17Dec 17, 2025

Questions about Leerink Partners and FOLD

What is Leerink Partners's price target for FOLD?
Leerink Partners's latest stated price target for Amicus Therapeutics Inc. (FOLD) is $14.50, from its action on Dec 29, 2025.
What is Leerink Partners's rating on FOLD?
Leerink Partners rates FOLD Market Perform, a neutral rating, as of Dec 29, 2025.
When did Leerink Partners last change its view on FOLD?
On Dec 29, 2025, Leerink Partners downgrades to Market Perform from Outperform, price target $14.50.
How does Leerink Partners's FOLD target compare with other analysts?
Across 4 firms with a FOLD price target in the last 12 months, the median target is $14.50. Leerink Partners's target matches it.

More FOLD rating histories

All Leerink Partners ratingsFOLD news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.